SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
-10.97%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$405M
AUM Growth
+$405M
(-25%)
Cap. Flow
-$58.7M
Cap. Flow
% of AUM
-14.49%
Top 10 Holdings %
Top 10 Hldgs %
35.11%
Holding
122
New
18
Increased
18
Reduced
51
Closed
9
Top Buys
| 1 |
Mineralys Therapeutics
MLYS
|
$4.36M |
| 2 |
Nova
NVMI
|
$4.16M |
| 3 |
MAZE
Maze Therapeutics, Inc. Common Stock
MAZE
|
$3.91M |
| 4 |
Sarepta Therapeutics
SRPT
|
$3.77M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
$3.47M |
Top Sells
| 1 |
BridgeBio Pharma
BBIO
|
$18.6M |
| 2 |
Microsoft
MSFT
|
$6.66M |
| 3 |
Meta Platforms (Facebook)
META
|
$6.36M |
| 4 |
Check Point Software Technologies
CHKP
|
$6.22M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$5.29M |
Sector Composition
| 1 | Healthcare | 78.9% |
| 2 | Technology | 13.54% |
| 3 | Consumer Discretionary | 2.19% |
| 4 | Communication Services | 2.14% |
| 5 | Utilities | 1.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Camtek
CAMT
$3.51B
| $1.35M | 0.31% |
23,086
-13,201
| -36% | -$774K |
|
77
ProMIS Neurosciences
PMN
$23.7M
| $1.34M | 0.31% |
1,929,297
| – | – |
|
|
SHLT
78
DELISTED
SHL Telemedicine Ltd American Depositary Shares
SHLT
| $1.31M | 0.3% |
632,456
| – | – |
|
79
Oric Pharmaceuticals
ORIC
$1.03B
| $1.31M | 0.3% |
234,834
-38,379
| -14% | -$214K |
|
80
CEVA Inc
CEVA
$520M
| $1.25M | 0.29% |
+48,920
| New | +$1.25M |
|
81
Bristol-Myers Squibb
BMY
$96.7B
| $1.22M | 0.28% |
20,000
| – | – |
|
82
Ventyx Biosciences
VTYX
$184M
| $1.16M | 0.27% |
1,012,749
| – | – |
|
|
NNDM
83
Nano Dimension
NNDM
$296M
| $1.14M | 0.26% |
+717,518
| New | +$1.14M |
|
|
INZY
84
DELISTED
Inozyme Pharma
INZY
| $1.08M | 0.25% |
1,191,140
| – | – |
|
85
Outlook Therapeutics
OTLK
$39.5M
| $1.05M | 0.24% |
+857,142
| New | +$1.05M |
|
86
Astria Therapeutics
ATXS
$394M
| $1.01M | 0.23% |
189,800
+50,000
| +36% | +$267K |
|
|
CMMB
87
Chemomab Therapeutics
CMMB
$15.7M
| $981K | 0.23% |
900,428
-314,147
| -26% | -$342K |
|
88
Perspective Therapeutics
CATX
$251M
| $980K | 0.23% |
460,247
| – | – |
|
89
Marvell Technology
MRVL
$53.7B
| $928K | 0.21% |
15,070
-63,541
| -81% | -$3.91M |
|
90
Arvinas
ARVN
$580M
| $878K | 0.2% |
+125,000
| New | +$878K |
|
91
Xenon Pharmaceuticals
XENE
$2.99B
| $876K | 0.2% |
26,097
-26,000
| -50% | -$872K |
|
92
Perion Network
PERI
$418M
| $835K | 0.19% |
102,612
| – | – |
|
|
RGLS
93
DELISTED
Regulus Therapeutics
RGLS
| $792K | 0.18% |
+452,845
| New | +$792K |
|
94
Larimar Therapeutics
LRMR
$337M
| $788K | 0.18% |
366,304
-89,300
| -20% | -$192K |
|
95
Corvus Pharmaceuticals
CRVS
$419M
| $655K | 0.15% |
205,859
-294,632
| -59% | -$937K |
|
96
Werewolf Therapeutics
HOWL
$62.6M
| $609K | 0.14% |
626,810
| – | – |
|
97
Vir Biotechnology
VIR
$765M
| $589K | 0.14% |
90,855
-490,974
| -84% | -$3.18M |
|
98
Aprea Therapeutics
APRE
$8.91M
| $551K | 0.13% |
270,000
| – | – |
|
99
Zura Bio
ZURA
$132M
| $543K | 0.13% |
421,229
-269,489
| -39% | -$348K |
|
100
Kezar Life Sciences
KZR
$28.5M
| $529K | 0.12% |
108,473
| – | – |
|